These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23846208)

  • 1. Retinal vascular precipitates during administration of melphalan into the ophthalmic artery.
    Superstein R; Lederer D; Dubois J; Hamel P; Carret AS; Callejo S
    JAMA Ophthalmol; 2013 Jul; 131(7):963-5. PubMed ID: 23846208
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlighting complications over successes in occurrence of sectoral choroidal occlusive vasculopathy.
    Abramson DH; Gobin YP; Dunkel I; Marr BP; Brodie S; Freund KB
    Retina; 2011 Sep; 31(8):1746; author reply 1747-8. PubMed ID: 21826040
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
    Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
    Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Arch Ophthalmol; 2010 Mar; 128(3):370-2. PubMed ID: 20212212
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular dysmotility after intra-arterial chemotherapy for retinoblastoma.
    Lambert NG; Winegar BA; Feola GP; Ramasubramanian A
    J AAPOS; 2015 Dec; 19(6):574-7. PubMed ID: 26691048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
    Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
    Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
    Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
    Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed Cerebral Infarction Following Intra-arterial Chemotherapy for Retinoblastoma.
    De la Huerta I; Seider MI; Hetts SW; Damato BE
    JAMA Ophthalmol; 2016 Jun; 134(6):712-4. PubMed ID: 27077487
    [No Abstract]   [Full Text] [Related]  

  • 10. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
    Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
    Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete regression of retinoblastoma following intra-arterial chemotherapy.
    Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
    J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
    Hutchinson A; Kaliki S; Shields CL
    J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
    Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
    Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR
    Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract]   [Full Text] [Related]  

  • 16. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
    Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
    Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
    Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
    Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
    Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.
    Fallaha N; Dubois J; Carret AS; Callejo SA; Hamel P; Superstein R
    Arch Ophthalmol; 2012 Aug; 130(8):1075-7. PubMed ID: 22893086
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
    Ong SJ; Chao AN; Wong HF; Liou KL; Kao LY
    Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.